Members: Login / Logout
Programme

Focus: Programme

The annual Training Day will take place on 6 June, and we are delighted to announce that Focus this year will also host the ACB Microbiology Professional Group Annual Scientific Meeting on 6 June. These events will be followed by an opening evening lecture and reception open to all delegates.
The Focus conference programme and exhibition will take place over 7 and 8 June.

Wednesday 6th June 2018 - Microbiology

Wednesday 6th June 2018 - Training Day

Thursday 7th June 2018 - Focus Day 1

Friday 8th June 2018 - Focus Day 2



Programme highlights are below:


Wednesday Evening general scientific interest Lecture - 'Murder and the Making of English CSI'
Prof Ian Burney, Centre for the History of Science, Technology & Medicine, University of Manchester

This year, prior to the opening reception, the Wednesday evening will feature an exciting talk of general scientific interest from Professor Ian Burney on the topic of his book 'Murder and the Making of English CSI'.

This talk will commence at 5.30pm and is free for all registered delegates of Focus, the Focus Training Day and/or the ACB Microbiology Professional Group Annual Scientific Meeting at Focus 2018.
Transatlantic Lecture -  Drug Screening with Immunoassays: Breaking Up is Hard To Do
Dr Dennis J. Dietzen,  President AACC

Dennis J. Dietzen, Ph.D., DABCC, FACB is Professor of Pathology & Immunology at Washington University where he directs the Core Laboratory and Metabolic Genetics Laboratory at St. Louis Children’s Hospital.  Dr. Dietzen received a Ph.D. in Biochemistry from Indiana University and completed a postdoctoral fellowship at Washington University.  Prior to his return to St. Louis in 2002, he was a chemist at DuPont Diagnostics (now a part of Siemens Healthcare Diagnostics) and served as Director of Clinical Laboratories at the Memphis Veterans Affairs Medical Center.
Dr. Dietzen has served the AACC in numerous capacities.  He was a member of the organizing committees for the 2001-2003 Oak Ridge Conferences and the 2007 & 2010 Annual Meetings. He chaired the 2013 Annual Meeting in Houston.  From 2001-2007, Dr. Dietzen was a member of the ABCC Board of Directors and was newsletter editor for Pediatric-Maternal Fetal Division from 2007-2010, and an original member of the Pediatric Reference Range Committee.
Dr. Dietzen is a member of the Academy of Clinical Laboratory Physicians and Scientists, the Society for Inherited Metabolic Disorders and the American Society for Mass Spectrometry.  He serves on the Editorial Board of Clinical Biochemistry and Critical Reviews in Clinical Laboratory Sciences and is Associate Editor of The Journal of Applied Laboratory Medicine.  He is an author/coauthor of more than 90 peer-reviewed publications, monographs, and chapters on wide range of subjects.  Dr. Dietzen was co-editor of the fourth edition of the Biochemical and Molecular Basis of Pediatric Disease published by AACC Press and is the author of the Amino Acid, Peptide, and Protein Chapter in the 6th edition of Tietz Textbook of Clinical Chemistry and Molecular Diagnostics.
Foundation Lecture -  Increasing access and equity in laboratory diagnostics
Dr Martin Myers,  Lancashire Teaching Hospitals NHS Foundation Trust
Dr Myers is a Consultant Clinical Biochemist at Lancashire Teaching Hospitals NHS Foundation Trust (LTH), Royal Preston Hospital, and Associate Divisional Medical Director for Pathology. Dr Myers has taken a lead role in a continuous program of Pathology re-design; improving the clinical and operational effectiveness of Pathology delivery.  His interests include the use of automation, point of care testing and informatics in improving the quality of the diagnostic process and redesigning pathology delivery. He is currently working on the “Laboratory Anywhere” concept where the “Lab in a Box” model delivers diagnostics in a variety of locations both inside and outside the hospital ensuring that diagnostics are embedded in the patient pathway, rather than remote from the patient.  He is involved in several projects for the direct delivery of diagnostics to BAME communities and vulnerable groups. Dr Myers is an advisor to the NHSE CSO team and is leading on the delivery of point of care diagnostics in patients with Learning Difficulties and patients experiencing Mental Health issues as well as translating NICE diagnostic recommendations for service delivery.
RCPath Flynn Lecture -  Demand Optimisation: Defining Value in Laboratory Services
Dr Bernie Croal,  NHS Grampian
Dr Bernie Croal is a Consultant Chemical Pathologist from Aberdeen, Scotland. He graduated in Honours Physiology (1989) and Medicine (1992) from Glasgow University and went on to train in General Medicine (FRCP 1998) and Clinical Biochemistry (FRCPath 1999). He moved to Aberdeen to take up an academic Senior Lecturer post in Health Services Research, obtaining an MSc (2000) and MD (2003) degree in Public Health and Health Services Research. He moved over to NHS Grampian in 2003 as Consultant and Clinical Director of Laboratory Medicine/Pathology. In 2009 he founded and was the first Clinical Lead of the Scottish Clinical Biochemistry Managed Diagnostic Network.
Over the last 10 years he has filled many roles at RCPath including Chairs of Scottish Council, the Clinical Biochemistry SAC, the Informatics Committee, the National Laboratory Medicine Catalogue and the Quality Assurance Management Group. At age 43, he was the joint youngest ever RCPath Vice-President (2011-14) and was a member of Council/Exec for 10 consecutive years, as well as a member of both ACB and IBMS Council.
His interest in Demand Optimisation stretches back to his MD work and he has chaired the Scottish Demand Optimisation Programme since 2015, now in implementation phase two. In 2017, he was appointed as Lead for the Scottish North Region Distributed Services Group – aimed at bringing together the Diagnostic services of the six Health Boards in the North of Scotland.
Parallel Sessions
- Paediatrics for non-specialist/DGH clinical and laboratory teams
- New approaches to clinical problems and drug assays
- 'Point of Care Testing at Focus'
- Access and equity in laboratory medicine
- ACB Medal Award
- Stem cell transplantation
- Horizon scanning
- 'FiLM at Focus'
- Impact of laboratory medicine on patient outcomes
- Clinical cases

Updated 20 March 2018

© Copyright The Association for Clinical Biochemistry and Laboratory Medicine
The Association for Clinical Biochemistry and Laboratory Medicine, 130-132 Tooley Street LONDON SE1 2TU
Tel: 020 7403 8001 Fax: 020 7403 8006